Delta-Fly Pharma株式会社 Stock: price and insider trades · Japan

Delta-Fly Pharma株式会社 is a listed company. Its directors and officers file their transactions with EDINET (Japan FSA). The last twelve months, up to 18 October 2026, brought 14 filings signed by 5 insiders.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Over the last twelve months, not one insider purchase of Delta-Fly Pharma株式会社 stock was filed. The median gap between a trade and its publication by EDINET (Japan FSA) is 7 days. Until a filing is published, the market cannot know about the trade.

With 14 filings in twelve months, the company is more active than the median of 3 filings across the 3,427 companies we follow on the same exchange.

This summary is built from EDINET (Japan FSA) disclosures alone and does not predict where the share price will go.